Imexpharm Corporation (HOSE: IMP)
94,400
Open93,900
High95,000
Low92,800
Vol29,300
Market Cap.7,269.22
Remain Bid500
Remain Ask1,900
52Wk High97,000
52Wk Low49,200
52Wk Avg Vol44,364
Foreign Buy2,300
Frgn Owned(%)49.40
Dividend2,000
Dividend Yield0.02
Beta0.58
EPS3,910
P/E23.81
F P/E15.42
BVPS29,679
P/B3.14
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| Date | Close | Change | Volume |
|---|---|---|---|
| 09/12/2024 | 94,400 | 1,300 (+1.40%) | 29,300 |
| 09/11/2024 | 93,100 | 100 (+0.11%) | 87,000 |
| 09/10/2024 | 93,000 | -3,200 (-3.33%) | 150,100 |
| 09/09/2024 | 96,200 | -800 (-0.82%) | 167,000 |
| 09/06/2024 | 97,000 | 5,700 (+6.24%) | 197,500 |
| 09/17/2024 | IMP Bonus share issue with 100.00% |
| 07/11/2024 | IMP Dividend payment in cash with 10.00% for 2023 (Record date) |
| 07/11/2024 | IMP Dividend payment in cash with 10.00% for 2023 |
| 07/11/2024 | IMP Dividend payment by share with 10.00% for 2023 (Record date) |
| 10/05/2023 | IMP Dividend payment in cash with 10.00% for 2022 (Record date) |
| 08/14/2024 | Explanation for FS the first 6 month of 2024 |
| 08/14/2024 | Reviewed FS the first 6 month of 2024 |
| 07/30/2024 | Corporate Governance Report the first 6 month of 2024 |
| 07/29/2024 | Regulations 2024 |
| 07/22/2024 | FS Quarter 2 of 2024 |
Name: Imexpharm Corporation
Abbreviation:IMEXPHARM
Address: No 4, Street 30/4, Ward 1, Cao Lanh Dong Thap
Telephone: (84.277) 385 1620
Fax: (84.277) 385 3106
Email:imp@imexpharm.com
Website:http://www.imexpharm.com
Exchange: HOSE
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 12/04/2006
Chartered capital: 770,382,810,000
Listed shares: 66,705,370
Shares outstanding: 66,671,570
Status: Operating
Tax code: 1400384433
Establishment license: 907/QĐTg
Issued date: 07/25/2001
Business license: 1400384433
Issued date: 08/01/2001
Main business scope:
- Manufacturing pharmaceuticals, traditional medicines, cosmetics, foods, soda and sterilizing substances.
- Trading pharmaceuticals, chemicals, medical equipment.
- Providing warehouse system.
- Others under business license.
- 28 September 1983: Dong Thap pharmaceutical enterprises, forerunner of the company. belonging to Dong Thap Health Department was established.
- November 1992: Renamed as Dong Thap Pharmaceutical company, belonging to Dong Thap People's Committee.
- November 1999: Renamed as Central Pharmaceutical Company No.7, belonging to Vietnam Pharmaceutical Company.
- July 2001: Transformed to Inexpharm Pharmaceutical Joint Stock Company with a charter capital of VND22 billion.
- March 2005: Increased the charter capital to VND44 billion.
- 04 December 2006: The company was listed on HOSE.
- 06 March 2017: Increased the charter capital to VND376,254,390,000;
- 15 June 2017: Increased the charter capital to VND429,781,510,000.
- 21 June 2018: Increased the charter capital to VND429,781,510,000.
- 31 July 2020: Increased the charter capital to VND642,360,700,000.
- 20 October 2020: Increased the charter capital to VND667,053,700,000.
- 09/17/2024 IMP Bonus share issue with 100.00%
- 08/16/2024 IMP Annoucement of the change of listing - 6,999,832 shares
- 08/08/2024 IMP Decision on the change of listing - 6,999,832 shares
- 07/11/2024 IMP Dividend payment in cash with 10.00% for 2023 (Record date)
- 07/11/2024 IMP Dividend payment by share with 10.00% for 2023 (Record date)
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
